Pain Management for Knee Osteoarthritis
Innovations in Genicular Outcomes Registry
Recruiting
Observational Study
Knee Osteoarthritis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Pacira Pharmaceuticals, Inc · Industry
Who this trial is looking for
This trial is looking for patients who have knee osteoarthritis and are planning to receive treatments for their pain, such as injections or surgery. Participants will provide information about their experiences and treatments through an app.
Are You a Good Fit for This Trial?
You may be able to join if
- I am planning to receive treatment for knee OA pain within 60 days.
- I can understand and complete questionnaires.
- I have access to a smartphone or a computer with internet.
You may not be able to join if
- I am actively enrolled in another trial that prevents me from standard care.
- I am planning to have surgery on a knee that is not the target knee.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The registry will capture prospective data on patients receiving pain management for chronic pain due to knee osteoarthritis (OA) or pain optimization for knee arthroplasty due to knee OA. The OA pain therapies may include cryo nerve block, radiofrequency ablation (RFA), intra-articular (IA) corticosteroids, viscosupplementation, opioids, and others (e.g., non-steroidal anti-inflammatory drugs \[N…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Planned to receive treatment for knee OA pain including, but not limited to, knee injections, nerve blocking procedures, or knee arthroplasty within 60 days of screening
2. Able to understand the informed consent and assessment questionnaires and have the ability to complete …
Contacts